The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1492
ISSUE1492
April 11, 2016
Buprenorphine Buccal Film (Belbuca) for Chronic Pain
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Buprenorphine Buccal Film (Belbuca) for Chronic Pain
April 11, 2016 (Issue: 1492)
Belbuca (Endo), a buccal formulation of the partial
opioid agonist buprenorphine, has been approved by the
FDA for management of pain severe enough to require
daily, around-the-clock, long-term opioid treatment.
Buprenorphine is also available as...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.